Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 31

Sort by

Sort Order Select

Journal Articles

Extracellular RNA released due to shear stress controls natural bypass growth by mediating mechanotransduction in mice

Manuel Lasch, Eike Christian Kleinert, Sarah Meister, Konda Kumaraswami, Judith-Irina Buchheim, Tobias Grantzow, Thomas Lautz, Sofia Salpisti, Silvia Fischer, Kerstin Troidl, Ingrid Fleming, Anna M. Randi, Markus Sperandio, Klaus T. Preissner, Elisabeth Deindl

Blood (2019) 134 (17): 1469–1479.

https://doi.org/10.1182/blood.2019001392

Published: 2019

Includes: Supplemental data

Journal Articles

Risk Factors for the Development of Cardiac Arrhythmias during Hematopoietic Stem Cell Transplantation

Christopher Kapolas, PharmD, Jane Kosirog-Glowacki, PharmD, Kathryn L Barney, NP, Linda Advincula, NP, Leonard M. Klein, MD, Jacob D. Bitran, MD, Shams Bufalino, Tulio E Rodriguez, MD

Blood (2018) 132 (Supplement 1): 3387.

https://doi.org/10.1182/blood-2018-99-120189

Published: 2018

Journal Articles

Genome-Wide Analysis of the Regulatory Landscape in Different Pre-B-ALL Subtypes

Mari Lahnalampi, MSc, Juha Mehtonen, MSc, Susanna Teppo, MSc, Saara Laukkanen, MSc, Laura Oksa, MSc, Markus Muschen, MD, Olli Lohi, MD PhD, Merja Heinäniemi, PhD

Blood (2017) 130 (Supplement 1): 3807.

https://doi.org/10.1182/blood.V130.Suppl_1.3807.3807

Published: 2017

Journal Articles

Therapeutic Targeting of HDAC3 in FOXO1-Mutant DLBCL

Kristy Stengel, PhD, Srividya Bhaskara, PhD, Jing Wang, PhD, Qi Liu, PhD, Scott Hiebert, PhD

Blood (2017) 130 (Supplement 1): 311.

https://doi.org/10.1182/blood.V130.Suppl_1.311.311

Published: 2017

Journal Articles

A Long Noncoding RNA from the HBS1L-MYB Intergenic Region on Chr6q23 Regulates Human Fetal Hemoglobin Expression

Tasha A. Morrison, MPH,BA, Ibifiri Wilcox, BS, Hong-Yuan Luo, PhD, John Farrell, PhD, Ryo Kurita, PhD, Yukio Nakamura, MD PhD, George J Murphy, PhD, Shuaiying Cui, PhD, Martin H. Steinberg, MD, David H.K. Chui, MD

Blood (2017) 130 (Supplement 1): 288.

https://doi.org/10.1182/blood.V130.Suppl_1.288.288

Published: 2017

Journal Articles

Graded PU.1 Levels Regulate Granulocyte Vs. Macrophage Genes Via Multiple Enhancer Elements

Vitek Pospisil, PhD, Pavle Krsmanovic, PhD, Jan Valecka, MSc, Kamila Chramostová, Vojtech Kulvait, MSc, Jiri Zavadil, PhD, Martin Vokurka, MD PhD, Peter Laslo, PhD, Tomas Stopka, MD PhD

Blood (2016) 128 (22): 403.

https://doi.org/10.1182/blood.V128.22.403.403

Published: 2016

Journal Articles

Final Results of a Phase 2 Trial of Extended Treatment (tx) with Carfilzomib (CFZ), Lenalidomide (LEN), and Dexamethasone (KRd) Plus Autologous Stem Cell Transplantation (ASCT) in Newly Diagnosed Multiple Myeloma (NDMM)

Todd Zimmerman, MD, Noopur S. Raje, Ravi Vij, Donna Reece, MD, Jesus G. Berdeja, MD, Leonor A Stephens, PhD, Kathryn McDonnell, Cara A. Rosenbaum, MD, Jagoda Jasielec, MD, Paul G Richardson, MD, Sandeep Gurbuxani, Jennifer Nam, Erica Severson, Brittany D. Wolfe, MMS, PA-C, Shaun Rosebeck, PhD, Andrew Stefka, Dominik Dytfeld, MD PhD, Kent Griffith, PhD, Andrzej Jakubowiak, MDPhD

Blood (2016) 128 (22): 675.

https://doi.org/10.1182/blood.V128.22.675.675

Published: 2016

Journal Articles

Long noncoding RNAs in B-cell development and activation

Tiago F. Brazão, Jethro S. Johnson, Jennifer Müller, Andreas Heger, Chris P. Ponting, Victor L. J. Tybulewicz

Blood (2016) 128 (7): e10–e19.

https://doi.org/10.1182/blood-2015-11-680843

Published: 2016

Includes: Supplemental data

Journal Articles

High Resolution Mapping of Active RNA Polymerases Identifies KIT As a Target of BET Inhibitors in t(8;21) AML

Yue Zhao, PhD, Phillip Liu, PhD, Peggy Scherle, PhD, Reid Huber, PhD, Michael R. Savona, MD, Scott Hiebert, PhD

Blood (2015) 126 (23): 1225.

https://doi.org/10.1182/blood.V126.23.1225.1225

Published: 2015

Journal Articles

Moderate Reduction in LVEF Is Associated with an Increased Risk of Post-HSCT Symptomatic Cardiomyopathy

Kinjal Parikh, MD, Lekha Mikkilineni, MD, Fern Martin, MD, Dolores Grosso, R.N., CRNP, DNP, Benjamin Leiby, PhD, Onder Alpdogan, MD, Matthew Carabasi, MD, Margaret Kasner, MD, Thomas R. Klumpp, MD, Ubaldo Martinez Outschoorn, MD, Manish Sharma, MD, Mark Weiss, MD, John L. Wagner, MD, Neal Flomenberg, MD, Joanne Filicko-O'Hara, MD

Blood (2015) 126 (23): 2023.

https://doi.org/10.1182/blood.V126.23.2023.2023

Published: 2015

Journal Articles

Pronostic Value of Pretransplant Echocardiography in Allogeneic Hematopoietic Cell Transplantation

Sarmiento Mauricio, MDPhD, Ildefonso Espigado, MD PhD, Rocio Parody, MD, Francisco Marquez, NR, Jose Falantes, MD, Teresa Caballero, PhD, Cristina Calderon, MD, Magdalena Carmona, MDPhD, Jose Lopez, MDPhD, Jose A. Perez-Simon, MD, PhD

Blood (2015) 126 (23): 4363.

https://doi.org/10.1182/blood.V126.23.4363.4363

Published: 2015

Journal Articles

Characterizing the Global Transcriptional Effects of TEL-AML1-Fusion in Childhood Acute Lymphoblastic Leukemia

Susanna Teppo, MSc, Kaisa J Teittinen, PhD, Toni Grönroos, MSc, Keijo Viiri, PhD, Minna Kaikkonen, PhD, Merja Heinäniemi, PhD, Olli Lohi, MD PhD

Blood (2014) 124 (21): 3794.

https://doi.org/10.1182/blood.V124.21.3794.3794

Published: 2014

Journal Articles

Elevated High Sensitivity Troponin T (HsTnT) during Front-Line Therapy with Cyclophosphamide, Doxorubicin, Vincristine and Prednisone +/- Rituximab (CHOP+/-R) or Cyclophosphamide, Epirubicin, Vincristine and Prednisone +/- Rituximab (CEpOP+/-R) Correlates with a Decline in Left Ventricular Ejection Fraction (LVEF) in Patients with Aggressive B-Cell Lymphoma: Results from a Randomized Prospective Clinical Trial NCT00854568

Kai Xue, MD, Juan J Gu, PhD, Qunling Zhang, MD, Xiaojian Liu, MD, Jiachen Wang, Jianfeng Luo, Francisco J. Hernandez-Ilizaliturri, MD, Stanley F. Fernandez, MD, Myron S. Czuczman, MD, Junning Cao, MD Associate Professor, Xiaonan Hong, MD, Ye Guo, MD

Blood (2014) 124 (21): 3041.

https://doi.org/10.1182/blood.V124.21.3041.3041

Published: 2014

Journal Articles

Left Ventricular Ejection Fraction Measurement and Doxorubicin-Based Chemotherapy in Patients with Diffuse Large B-Cell Lymphoma

Deborah L Enns, PhD, David M Aboulafia, MD

Blood (2014) 124 (21): 1300.

https://doi.org/10.1182/blood.V124.21.1300.1300

Published: 2014

Journal Articles

Epirubincin Does Not Lower The Risk Of Cardiac Toxicity Than Doxorubicin In Diffuse Large B-Cell Lymphoma (DLBCL) and Follicular Lymphoma Grade 3 (FLG3): Results From a 398-Case Prospective Randomized Phase III Clinical Trial (NCT00854568)

Kai Xue, MD, Zhang Qunling, MD, Xiaojian Liu, MD, Junning Cao, MD, Xiaonan Hong, MD, Ye Guo, MD

Blood (2013) 122 (21): 372.

https://doi.org/10.1182/blood.V122.21.372.372

Published: 2013

Journal Articles

Utility Of Routine Left Ventricular Ejection Fraction (LVEF) Measurement Prior To Administration Of Anthracycline-Based Chemotherapy In Patients With Diffuse Large B-Cell Lymphoma (DLBCL)

Deborah L Enns, PhD, David Aboulafia, MD

Blood (2013) 122 (21): 5599.

https://doi.org/10.1182/blood.V122.21.5599.5599

Published: 2013

Journal Articles

Fatal Thrombotic Microangiopathy Developing within 24 Hours of Carfilzomib in a Patient with Relapsed Multiple Myeloma (MM)

Shebli Atrash, MD, Amy Joiner, K, MD, Bart Barlogie, MD, PHD, Stephen Medlin, DO, FACP

Blood (2012) 120 (21): 5037.

https://doi.org/10.1182/blood.V120.21.5037.5037

Published: 2012

Journal Articles

Utility of Pre-Induction Cardiac Function Testing in Patients with Newly Diagnosed AML

Adam Bryant, MD, Dawn Sheppard, MD, MSc, FRCPC, Christopher Bredeson, MD, MSc, FRCPC, Mitchell Sabloff, MDCM, FRCPC, MSc

Blood (2012) 120 (21): 2068.

https://doi.org/10.1182/blood.V120.21.2068.2068

Published: 2012

Journal Articles

HCT-CI Does Not Reliably Predict Outcome Following Allogeneic Stem Cell Transplant Due to Poor Correlation Between Clinical and Laboratory Assessment of Comorbidities

John Murray, RGN, MSc, Mike Dennis, MD, MRCP, FRCPath, James Cavet, PhD, FRCP, FRCPath, Samar Kulkarni, MD, MRCP, FRCPath, Adrian JC Bloor, PhD, FRCP, FRCPath

Blood (2011) 118 (21): 4562.

https://doi.org/10.1182/blood.V118.21.4562.4562

Published: 2011

Journal Articles

Prologed Use of Pegylated Liposomal Doxorubicin In An HIV-Infected Population with Kaposi's Sarcoma at An Inner-City Safety Net Hospital

Manila Gaddh, MD, Bernice Fokum, Hamid Bouiri, PharmD, MBA, Augustin Haidau, MD, Margaret Telfer, MD

Blood (2010) 116 (21): 4873.

https://doi.org/10.1182/blood.V116.21.4873.4873

Published: 2010

NARROW

Extracellular RNA released due to shear stress controls natural bypass growth by mediating mechanotransduction in mice

Risk Factors for the Development of Cardiac Arrhythmias during Hematopoietic Stem Cell Transplantation

Genome-Wide Analysis of the Regulatory Landscape in Different Pre-B-ALL Subtypes

Therapeutic Targeting of HDAC3 in FOXO1-Mutant DLBCL

A Long Noncoding RNA from the HBS1L-MYB Intergenic Region on Chr6q23 Regulates Human Fetal Hemoglobin Expression

Graded PU.1 Levels Regulate Granulocyte Vs. Macrophage Genes Via Multiple Enhancer Elements

Final Results of a Phase 2 Trial of Extended Treatment (tx) with Carfilzomib (CFZ), Lenalidomide (LEN), and Dexamethasone (KRd) Plus Autologous Stem Cell Transplantation (ASCT) in Newly Diagnosed Multiple Myeloma (NDMM)

Long noncoding RNAs in B-cell development and activation

High Resolution Mapping of Active RNA Polymerases Identifies KIT As a Target of BET Inhibitors in t(8;21) AML

Moderate Reduction in LVEF Is Associated with an Increased Risk of Post-HSCT Symptomatic Cardiomyopathy

Pronostic Value of Pretransplant Echocardiography in Allogeneic Hematopoietic Cell Transplantation

Characterizing the Global Transcriptional Effects of TEL-AML1-Fusion in Childhood Acute Lymphoblastic Leukemia

Left Ventricular Ejection Fraction Measurement and Doxorubicin-Based Chemotherapy in Patients with Diffuse Large B-Cell Lymphoma

Epirubincin Does Not Lower The Risk Of Cardiac Toxicity Than Doxorubicin In Diffuse Large B-Cell Lymphoma (DLBCL) and Follicular Lymphoma Grade 3 (FLG3): Results From a 398-Case Prospective Randomized Phase III Clinical Trial (NCT00854568)

Utility Of Routine Left Ventricular Ejection Fraction (LVEF) Measurement Prior To Administration Of Anthracycline-Based Chemotherapy In Patients With Diffuse Large B-Cell Lymphoma (DLBCL)

Fatal Thrombotic Microangiopathy Developing within 24 Hours of Carfilzomib in a Patient with Relapsed Multiple Myeloma (MM)

Utility of Pre-Induction Cardiac Function Testing in Patients with Newly Diagnosed AML

HCT-CI Does Not Reliably Predict Outcome Following Allogeneic Stem Cell Transplant Due to Poor Correlation Between Clinical and Laboratory Assessment of Comorbidities

Prologed Use of Pegylated Liposomal Doxorubicin In An HIV-Infected Population with Kaposi's Sarcoma at An Inner-City Safety Net Hospital

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only